| Literature DB >> 26497040 |
Luca Miele1,2, Valentina Giorgio3, Maria Adele Alberelli4, Erica De Candia5, Antonio Gasbarrini6, Antonio Grieco7.
Abstract
Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.Entities:
Keywords: Cardiovascular disease; Gut microbiota; Obesity; Platelets; Type 2 diabetes
Mesh:
Year: 2015 PMID: 26497040 DOI: 10.1007/s11886-015-0671-z
Source DB: PubMed Journal: Curr Cardiol Rep ISSN: 1523-3782 Impact factor: 2.931